Document Detail


PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice.
MedLine Citation:
PMID:  15319270     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: In endotoxemia, lipopolysaccharide (LPS) induces a systemic inflammatory response and intravascular coagulation. Monocytes orchestrate the innate immune response to LPS by expressing a variety of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), and the procoagulant molecule, tissue factor (TF). In this study, we analyzed the role of the phosphoinositide 3-kinase (PI3K)-Akt pathway in the activation of coagulation and the innate immune response in a mouse model of endotoxemia.
METHODS AND RESULTS: Wortmannin and LY294002 were used to inhibit the PI3K-Akt pathway. We found that wortmannin inhibited LPS-induced Akt phosphorylation in blood cells. Inhibition of the PI3K-Akt pathway significantly increased TF mRNA expression in blood cells, TF antigen, and thrombin-antithrombin III levels in the plasma, and fibrin deposition in the liver of endotoxemic mice. Inhibition of the PI3K-Akt pathway also strongly enhanced LPS-induced cytokine expression and the levels of soluble E-selectin in the plasma, suggesting enhanced activation of both monocytes and endothelial cells. Wortmannin treatment also increased the number of macrophages in the liver and kidney of endotoxemic mice. Finally, wortmannin and LY294002 dramatically reduced the survival time of endotoxemic mice.
CONCLUSIONS: These data suggest that the PI3K-Akt pathway suppresses LPS-induced inflammation and coagulation in endotoxemic mice.
Authors:
Gernot Schabbauer; Michael Tencati; Brian Pedersen; Rafal Pawlinski; Nigel Mackman
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2004-08-19
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  24     ISSN:  1524-4636     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-08     Completed Date:  2005-03-24     Revised Date:  2012-06-22    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1963-9     Citation Subset:  IM    
Affiliation:
Department of Immunology, The Scripps Research Institute, La Jolla, Calif 92037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Androstadienes / pharmacology
Animals
Blood Coagulation / physiology*
Chemokines / metabolism,  physiology
Chromones / pharmacology
Cytokines / metabolism,  physiology
Disease Models, Animal
Endothelial Cells / drug effects,  physiology
Endothelium, Vascular / drug effects,  physiology
Endotoxemia / metabolism*,  mortality
Humans
Inflammation / metabolism
Kidney / pathology
Lipopolysaccharides / immunology
Liver / pathology
Macrophage Activation / physiology
Mice
Mice, Inbred C57BL
Monocytes / physiology
Morpholines / pharmacology
Phosphatidylinositol 3-Kinases / antagonists & inhibitors,  metabolism*
Protein-Serine-Threonine Kinases / antagonists & inhibitors,  metabolism*
Proto-Oncogene Proteins / antagonists & inhibitors,  metabolism*
Proto-Oncogene Proteins c-akt
Signal Transduction / physiology
Grant Support
ID/Acronym/Agency:
HL48872/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Androstadienes; 0/Chemokines; 0/Chromones; 0/Cytokines; 0/Lipopolysaccharides; 0/Morpholines; 0/Proto-Oncogene Proteins; 154447-36-6/2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; 19545-26-7/wortmannin; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.11.1/AKT1 protein, human; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase A...
Next Document:  In vivo transcriptional response of cardiac endothelium to lipopolysaccharide.